Q2 2018

Filed Aug 2, 2018 · 10-Q · 33 days after period end · 0001104506-18-000008

Q2 2018 · 10-Q

Revenue

$0.00

— vs Q2 2017

Net Income

-$76.44M

N/M vs Q2 2017

EPS Diluted

-$1.00

N/M vs Q2 2017

Gross Profit$0—

Operating Income

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016	Q2 2015
Revenue	$0.00	$0.00	$0.00	—
Net Income	-$76.44M	-$44.67M	-$36.58M	-$28.61M
EPS Diluted	-$1.00	-$0.72	-$0.59	-$0.47

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR